Amgen to redeem all 3.45%, 4.1%, 1.85% notes, some 3.875% notes

By Sarah Lizee

Olympia, Wash., Feb. 18 – Amgen Inc. plans to redeem in full its $900 million 3.45% senior notes due Oct. 1, 2020, its $1 billion 4.1% senior notes due June 15, 2021 and its $750 million 1.85% senior notes due Aug. 19, 2021 and some of its $1.75 billion 3.875% senior notes due Nov. 15, 2021 using proceeds from a new issue, according to a 424B3 filing with the Securities and Exchange Commission.

The redemption for each series will include payment of a make-whole amount and accrued interest to but excluding the redemption date.

The company said it is preparing to sell a five-part offering of fixed-rate senior notes.

Remaining proceeds will be used to repay outstanding debt and for general corporate purposes.

Amgen is a Thousand Oaks, Calif., manufacturer and marketer of human therapeutics based upon advances in cellular and molecular biology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.